Autopsy report · NCT03816852

The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency

“Others”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Suspended: paused, and may or may not restart.
• 12 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 2

Sponsor

Sclnow Biotechnology Co., Ltd.

Sponsor type

Industry

Conditions

Premature Ovarian Failure

Interventions

hucMSCs

Participants

12 (planned, not actual)

Sites

1

Countries

China

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.